Table 3.
Univariate and multivariate Cox regression analyses of disease‐free survival
| Univariate Cox regression | Multivariate Cox regression | |||
|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | |
| Sex | ||||
| Female | 1.00 | – | 1.00 | – |
| Male | 1.988 | 0.942–4.199 | 2.417 | 1.132–5.161 |
| Age (years) | ||||
| <60 | 1.00 | – | 1.00 | – |
| ≥60 | 0.848 | 0.495–1.453 | 0.867 | 0.502–1.497 |
| Stage (AJCC) | ||||
| II | 1.00 | – | 1.00 | – |
| III | 5.282 | 2.653–10.516 | 5.599 | 2.791–11.232 |
| Location | ||||
| NGEJ | 1.00 | – | 1.00 | – |
| GEJ | 1.309 | 0.705–2.430 | 1.095 | 0.575–2.084 |
| Differentiation | ||||
| Intermediate | 1.00 | ‐ | 1.00 | – |
| Poor | 1.586 | 0.899–2.799 | 1.486 | 0.832–2.655 |
| Adjuvant therapy | ||||
| Chemo | 1.00 | ‐ | 1.00 | – |
| Chemo/CIT | 0.549 | 0.311–0.970 | 0.478 | 0.266–0.858 |
AJCC, American Joint Committee on Cancer; CIT, chemotherapy with cellular immunotherapy.